FDU-NNE1
 | |
| Systematic (IUPAC) name | |
|---|---|
|
[1-(4-fluorobenzyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide | |
| Clinical data | |
| Legal status |
|
| Chemical data | |
| Formula | C26H19FN2O |
| Molar mass | 394.4 g/mol |
| |
| |
FDU-NNE1 (also known as FDU-NNEI and FDU-MN-24) is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1][2]
See also
References
- ↑ "FDU-NNEI". Cayman Chemical. Retrieved 23 July 2015.
- ↑ Nahoko Uchiyama, Yoshihiko Shimokawa, Ruri Kikura-Hanajiri, Yosuke Demizu, Yukihiro Goda, Takashi Hakamatsuka (February 2015). "A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N–OH-EDMA, and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal products". Forensic Toxicology. doi:10.1007/s11419-015-0268-7.
This article is issued from Wikipedia - version of the Friday, February 05, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.